Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1988-6-16
pubmed:abstractText
The recent molecular cloning of the complementary DNA encoding T cell--replacing factor (TRF) has demonstrated that a single molecule is responsible for B cell growth factor II (BCGF-II) activity and eosinophil differentiation activity. It has been proposed that this molecule be called interleukin 5 (IL-5). We previously reported that purified rIL-5 supports the terminal differentiation and proliferation of eosinophilic precursors. In this study, we examined the effects of IL-5 on functional activities of mature eosinophils. IL-5 maintained the viability of mature eosinophils obtained from peritoneal exudate cells of mice infected with parasites. It also induced superoxide anion production in a dose-dependent manner. The Boyden's chamber Millipore assay revealed that IL-5 had a marked chemokinetic effect on eosinophils in a dose-dependent manner. Moreover, IL-5 was found to be an eosinophil chemotactic factor by the checkerboard assay. In conclusion, IL-5 is suggested to play an important role in increasing the functional activities of eosinophils as well as their production in allergic and parasitic diseases.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/2835420-13930964, http://linkedlifedata.com/resource/pubmed/commentcorrection/2835420-14316948, http://linkedlifedata.com/resource/pubmed/commentcorrection/2835420-2440025, http://linkedlifedata.com/resource/pubmed/commentcorrection/2835420-2823259, http://linkedlifedata.com/resource/pubmed/commentcorrection/2835420-3110787, http://linkedlifedata.com/resource/pubmed/commentcorrection/2835420-3257253, http://linkedlifedata.com/resource/pubmed/commentcorrection/2835420-3484551, http://linkedlifedata.com/resource/pubmed/commentcorrection/2835420-3484805, http://linkedlifedata.com/resource/pubmed/commentcorrection/2835420-3495002, http://linkedlifedata.com/resource/pubmed/commentcorrection/2835420-3871109, http://linkedlifedata.com/resource/pubmed/commentcorrection/2835420-3872907, http://linkedlifedata.com/resource/pubmed/commentcorrection/2835420-3902470, http://linkedlifedata.com/resource/pubmed/commentcorrection/2835420-4568301, http://linkedlifedata.com/resource/pubmed/commentcorrection/2835420-4697835, http://linkedlifedata.com/resource/pubmed/commentcorrection/2835420-4822532, http://linkedlifedata.com/resource/pubmed/commentcorrection/2835420-6159416, http://linkedlifedata.com/resource/pubmed/commentcorrection/2835420-6322187, http://linkedlifedata.com/resource/pubmed/commentcorrection/2835420-909604
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0022-1007
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
167
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1737-42
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1988
pubmed:articleTitle
Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor.
pubmed:affiliation
Department of Medicine, Jichi Medical School, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't